Realizing The Burden Of Invasive Pneumococcal Disease In Developing Countries

Published Oct 8, 2013
Kuala Lumpur, Malaysia – The World Health Organization (WHO) estimates that 1.6 million people die from pneumococcal disease every year. The vast majority of its victims come from developing countries. In the study, “Clinical Burden of Invasive Pneumococcal Disease in Selected Developing Countries,” published in Value in Health Regional Issues, researchers from the United Nations University, International Institute for Global Health and the UKM Medical Centre, provide a detailed review of articles published on the clinical burden of invasive pneumococcal disease [IPD] in developing countries in East Asia, South Asia, Middle East, Sub-Saharan Africa and Latin America. While the incidence and case fatality rate (CFR) of IPD differed from country to country and region to region, the review confirmed that the clinical burden of IPD is high in developing countries. The disease burden was not significantly different among the countries which belong to upper middle income category. Dr. Namaitijiang Maiamiti, MPH, PhD, postdoctoral fellow at the United Nations University-International Institute for Global Health (UNU-IIGH), says: “In order to convince policy makers to take action to control IPD, they need strong research based evidence.”
Value in Health Regional Issues  (ISSN 2212-1099) is a scientific journal that encourages and enhances the science of pharmacoeconomic/health economic and health outcomes research and its use in health care decisions. The journal is published up to three times a year with one issue focusing on the Asia region, one issue focusing on the Latin America region, and one issue focusing on the Central & Eastern Europe, Western Asia and Africa regions. The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health.

Related Stories

Value in Health Regional Issues Expands Editorial Scope and Reveals Plans to Transition to Gold Open Access Model

Jan 23, 2024

Value in Health Regional Issues, an official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the expansion of its editorial scope and its plan to transition to a gold open access journal.

Empowering Change: Transforming Health Systems in Low- and Middle-Income Countries

Jan 22, 2024

ISPOR announced the publication of a special themed section of research papers in Value in Health Regional Issues that highlight innovative approaches to improving health outcomes in low- and middle-income countries through partnerships between health economics researchers and policy makers.

ISPOR’s Value in Health Regional Issues Receives Its First Impact Factor Score

Aug 7, 2023

Value in Health Regional Issues, the regionally focused journal of ISPOR, received its first-ever impact factor score this year. Value in Health, one of the top-ranked journals in the HEOR field, maintained its high ranking on the prestigious list of scholarly journals.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on Update my browser now